Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMC 1773092)

Published in Gut on February 01, 2002

Authors

G Lindgren1, A Liljegren, E Jaramillo, C Rubio, A Lindblom

Author Affiliations

1: Department of Clinical Genetics, Karolinska Hospital, S 171 76 Stockholm, Sweden.

Associated clinical trials:

High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome. (EndoLynch) | NCT02951390

Articles citing this

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) (2010) 2.86

Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ (2005) 2.26

Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. J Clin Oncol (2008) 1.23

Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet (2006) 1.18

Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients. Clin Dev Immunol (2010) 1.12

Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) (2008) 1.11

Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut (2003) 1.06

A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer. Gut (2005) 1.01

Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn (2009) 0.96

Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut (2003) 0.96

Colonic adenoma risk in familial colorectal cancer--a study of six extended kindreds. Am J Gastroenterol (2008) 0.94

TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer (2009) 0.90

Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis. J Mol Diagn (2005) 0.90

Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer. Am J Surg Pathol (2008) 0.89

Clinical significance of microsatellite instability in colorectal cancer. Langenbecks Arch Surg (2013) 0.87

Association of colorectal adenoma with other malignancies in Swedish families. Br J Cancer (2008) 0.83

Interval colon cancer in a Lynch syndrome patient under annual colonoscopic surveillance: a case for advanced imaging techniques? BMC Gastroenterol (2012) 0.83

Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters. PLoS One (2015) 0.82

Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case. Fam Cancer (2015) 0.81

The genetic variant on chromosome 10p14 is associated with risk of colorectal cancer: results from a case-control study and a meta-analysis. PLoS One (2013) 0.81

Colorectal cancer screening in patients at moderately increased risk due to family history. World J Gastrointest Oncol (2012) 0.80

Genetic mechanisms in interval colon cancers. Dig Dis Sci (2014) 0.80

Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC). Med Oncol (2014) 0.78

Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLoS Med (2016) 0.75

A comprehensive meta-analysis of genetic associations between five key SNPs and colorectal cancer risk. Oncotarget (2016) 0.75

Evaluation of the left-to-right shift of colon tumors in Iran: Is the trend changing? J Res Med Sci (2015) 0.75

Articles cited by this

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res (1998) 20.08

Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52

Microsatellite instability in cancer of the proximal colon. Science (1993) 14.51

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41

Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology (1997) 7.58

Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73

Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43

Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet (1999) 4.16

Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer (1993) 3.86

Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (1995) 3.45

Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41

Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut (1982) 3.23

Family studies in cancer of the colon and rectum. Br J Surg (1976) 3.01

Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med (1993) 2.61

Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut (1992) 2.15

Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst (1990) 2.11

Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer (1985) 2.08

Evolution of hereditary non-polyposis colorectal cancer. Gut (1992) 1.70

Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer (1997) 1.57

Hereditary non-polyposis colorectal cancer--morphologies, genes and mutations. Mutat Res (1994) 1.46

Colorectal adenomas in the Lynch syndromes. Results of a colonoscopy screening program. Gastroenterology (1990) 1.26

Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test (1999) 1.14

Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet (1997) 1.06

Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer (2000) 1.04

Frequency and type of colorectal tumors in asymptomatic high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Cancer Epidemiol Biomarkers Prev (1998) 0.86

Reliability of colonoscopy. Dis Colon Rectum (1989) 0.85

Family history increases the risk of colorectal cancer. Gastroenterology (1995) 0.80

Articles by these authors

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04

Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ (2009) 3.62

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis (2004) 2.87

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75

Regular review: tumour markers in malignancies. BMJ (2000) 2.65

Flat neoplastic lesions of the colon and rectum detected by high-resolution video endoscopy and chromoscopy. Gastrointest Endosc (1995) 2.22

Comparison of genetic divergence and fitness between two subclones of Helicobacter pylori. Infect Immun (2001) 1.98

Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat (1997) 1.88

Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A (2001) 1.80

Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis (2001) 1.80

A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer (1998) 1.79

Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res (2001) 1.70

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60

Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant (2010) 1.59

Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol Biol Cell (1994) 1.56

Investigation on tumour spread in connection with aspiration biopsy. Acta Radiol Ther Phys Biol (1971) 1.56

Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand A (1983) 1.46

Mechanisms of reduced susceptibility to amoxycillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain). Clin Microbiol Infect (2004) 1.46

Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44

The social determinants of health: key to global tuberculosis control. Int J Tuberc Lung Dis (2011) 1.44

Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy. Gastrointest Endosc (1996) 1.43

[Pressing problems in primary care]. Aten Primaria (2001) 1.39

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36

Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis (2001) 1.36

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects. Int J Tuberc Lung Dis (2011) 1.35

High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer (1995) 1.34

Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol (2001) 1.32

Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31

Origin of tripronucleate zygotes after intracytoplasmic sperm injection. Hum Reprod (1997) 1.31

Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis (2011) 1.30

A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics (1998) 1.30

Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia (2013) 1.27

The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res (2001) 1.20

Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest (2001) 1.19

Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet (2006) 1.18

Maxillary sinusitis caused by Schizophyllum commune and experience with treatment. J Med Vet Mycol (1998) 1.17

Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res (1995) 1.17

Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol (2000) 1.17

Anticholinergic medication in diagnostic endoscopy of the upper gastrointestinal tract. Endoscopy (1991) 1.16

Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy (2006) 1.16

Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum (2002) 1.14

The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res (1998) 1.14

Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test (1999) 1.14

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res (1998) 1.12

A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer (2010) 1.11

Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. Haemophilia (2013) 1.11

A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet (2008) 1.11

The heparin-glutathione test: an alternative to the hypo-osmotic swelling test to select viable sperm for intracytoplasmic sperm injection. Fertil Steril (1998) 1.11

COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer (2001) 1.10

A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet (1998) 1.10

High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer. J Med Genet (2005) 1.10

Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test (2005) 1.10

ATM mutations in cancer families. Cancer Res (1996) 1.09

Helicobacter pylori in 205 consecutive endoscopy patients. Scand J Infect Dis (1993) 1.09

Intracytoplasmic testicular sperm injection: an effective treatment for otherwise intractable obstructive azoospermia. J Urol (1995) 1.09

Replication and assembly of VSV nucleocapsids: protein association with RNPs and the effects of cycloheximide on replication. Virology (1980) 1.09

Oral sedation for diagnostic upper endoscopy. Endoscopy (1991) 1.08

Refractive acoustic devices for airborne sound. Phys Rev Lett (2001) 1.07

MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res (2001) 1.06

Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet (1997) 1.06

Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut (2003) 1.06

Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? Endoscopy (2005) 1.05

Differentiation of three biotypes of Malassezia species on human normal skin. correspondence with M. globosa, M. sympodialis and M. restricta. Mycopathologia (1999) 1.05

FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J Assist Reprod Genet (1998) 1.05

A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med (2001) 1.04

Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins. Antimicrob Agents Chemother (2001) 1.04

Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer (2000) 1.04

Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res (2001) 1.04

Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimen. Br J Radiol (1999) 1.04

Classification of colorectal polyps: guidelines for the endoscopist. Endoscopy (2002) 1.03

Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet (2004) 1.03

Aspiration biopsy of mammary tumors in diagnosis and research--a critical review of 2,200 cases. Acta Cytol (1967) 1.02

Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer (2000) 1.01

A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer. Gut (2005) 1.01

Cell-type-specific regulation of the two foamy virus promoters. J Virol (2001) 1.00

Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction. Mutat Res (1998) 1.00

Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon. Gastroenterology (2001) 1.00

Visualization of hydatid elements: comparison of several techniques. J Clin Microbiol (1999) 1.00

Ki-ras mutations and prognosis in colorectal cancer. Eur J Cancer (1998) 0.99